JPWO2021065306A1 - - Google Patents
Info
- Publication number
- JPWO2021065306A1 JPWO2021065306A1 JP2021550469A JP2021550469A JPWO2021065306A1 JP WO2021065306 A1 JPWO2021065306 A1 JP WO2021065306A1 JP 2021550469 A JP2021550469 A JP 2021550469A JP 2021550469 A JP2021550469 A JP 2021550469A JP WO2021065306 A1 JPWO2021065306 A1 JP WO2021065306A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N2440/14—Post-translational modifications [PTMs] in chemical analysis of biological material phosphorylation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025042343A JP2025098086A (ja) | 2019-09-30 | 2025-03-17 | 血液試料を検体とするタウタンパク質検出方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019179385 | 2019-09-30 | ||
| JP2019179385 | 2019-09-30 | ||
| PCT/JP2020/033211 WO2021065306A1 (ja) | 2019-09-30 | 2020-09-02 | 血液試料を検体とするタウタンパク質検出方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025042343A Division JP2025098086A (ja) | 2019-09-30 | 2025-03-17 | 血液試料を検体とするタウタンパク質検出方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021065306A1 true JPWO2021065306A1 (https=) | 2021-04-08 |
| JP7718270B2 JP7718270B2 (ja) | 2025-08-05 |
Family
ID=75338154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021550469A Active JP7718270B2 (ja) | 2019-09-30 | 2020-09-02 | 血液試料を検体とするタウタンパク質検出方法 |
| JP2025042343A Pending JP2025098086A (ja) | 2019-09-30 | 2025-03-17 | 血液試料を検体とするタウタンパク質検出方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025042343A Pending JP2025098086A (ja) | 2019-09-30 | 2025-03-17 | 血液試料を検体とするタウタンパク質検出方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220365102A1 (https=) |
| EP (1) | EP4040153A4 (https=) |
| JP (2) | JP7718270B2 (https=) |
| WO (1) | WO2021065306A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023056410A1 (en) * | 2021-10-01 | 2023-04-06 | Integrated Neurologics LLC | Methods and devices for detecting cerebrospinal fluid leakage |
| WO2024214588A1 (ja) * | 2023-04-13 | 2024-10-17 | 国立研究開発法人量子科学技術研究開発機構 | 被験者の脳のタウタンパク質の蓄積量を推定する方法及び装置 |
| JP7450995B1 (ja) | 2023-04-13 | 2024-03-18 | 国立研究開発法人量子科学技術研究開発機構 | 被験者の脳のタウタンパク質の蓄積量を推定する方法及び装置 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5492812A (en) * | 1991-08-01 | 1996-02-20 | Provost, Fellows And Scholars Of Trinity College | Diagnostic method for Alzheimer's disease by screening for tau-peptides in the blood of a patient |
| JPH08503898A (ja) * | 1992-03-05 | 1996-04-30 | ロウバー グループ リミテッド | 複式射出成形方法および当該方法で形成される成形体 |
| US20150018223A1 (en) * | 2010-01-28 | 2015-01-15 | University Of Massachusetts Lowell | Methods of diagnosing tau-associated neurodegenerative diseases |
| WO2017138497A1 (ja) * | 2016-02-08 | 2017-08-17 | シスメックス株式会社 | 被検物質の検出方法および被検物質の検出用試薬キット |
| JP2017531796A (ja) * | 2014-09-30 | 2017-10-26 | ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | タウの動態測定 |
| WO2018106776A2 (en) * | 2016-12-07 | 2018-06-14 | Genentech, Inc. | Anti-tau antibodies and methods of use |
| JP2019027952A (ja) * | 2017-07-31 | 2019-02-21 | 京都府公立大学法人 | リン酸化タウタンパク質の測定方法 |
| US20190271710A1 (en) * | 2018-03-05 | 2019-09-05 | Janssen Pharmaceutica Nv | Assays to detect neurodegeneration |
| WO2020105700A1 (ja) * | 2018-11-22 | 2020-05-28 | 富士レビオ株式会社 | 抗体コンジュゲート |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994013795A1 (en) * | 1992-12-14 | 1994-06-23 | N.V. Innogenetics S.A. | Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| PL2857039T3 (pl) | 2012-05-31 | 2020-05-18 | Osaka City University | Środek terapeutyczny lub środek profilaktyczny na otępienie |
-
2020
- 2020-09-02 US US17/764,931 patent/US20220365102A1/en active Pending
- 2020-09-02 JP JP2021550469A patent/JP7718270B2/ja active Active
- 2020-09-02 EP EP20873277.6A patent/EP4040153A4/en active Pending
- 2020-09-02 WO PCT/JP2020/033211 patent/WO2021065306A1/ja not_active Ceased
-
2025
- 2025-03-17 JP JP2025042343A patent/JP2025098086A/ja active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5492812A (en) * | 1991-08-01 | 1996-02-20 | Provost, Fellows And Scholars Of Trinity College | Diagnostic method for Alzheimer's disease by screening for tau-peptides in the blood of a patient |
| JPH08503898A (ja) * | 1992-03-05 | 1996-04-30 | ロウバー グループ リミテッド | 複式射出成形方法および当該方法で形成される成形体 |
| US20150018223A1 (en) * | 2010-01-28 | 2015-01-15 | University Of Massachusetts Lowell | Methods of diagnosing tau-associated neurodegenerative diseases |
| JP2017531796A (ja) * | 2014-09-30 | 2017-10-26 | ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | タウの動態測定 |
| WO2017138497A1 (ja) * | 2016-02-08 | 2017-08-17 | シスメックス株式会社 | 被検物質の検出方法および被検物質の検出用試薬キット |
| WO2018106776A2 (en) * | 2016-12-07 | 2018-06-14 | Genentech, Inc. | Anti-tau antibodies and methods of use |
| JP2019027952A (ja) * | 2017-07-31 | 2019-02-21 | 京都府公立大学法人 | リン酸化タウタンパク質の測定方法 |
| US20190271710A1 (en) * | 2018-03-05 | 2019-09-05 | Janssen Pharmaceutica Nv | Assays to detect neurodegeneration |
| WO2020105700A1 (ja) * | 2018-11-22 | 2020-05-28 | 富士レビオ株式会社 | 抗体コンジュゲート |
Non-Patent Citations (1)
| Title |
|---|
| CHEN ZHICHENG ET AL.: "Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzh", ALZHEIMER'S & DEMENTIA, vol. 15, no. 3, JPN6020043680, 9 November 2018 (2018-11-09), pages 487 - 496, ISSN: 0005485379 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025098086A (ja) | 2025-07-01 |
| US20220365102A1 (en) | 2022-11-17 |
| EP4040153A1 (en) | 2022-08-10 |
| WO2021065306A1 (ja) | 2021-04-08 |
| JP7718270B2 (ja) | 2025-08-05 |
| EP4040153A4 (en) | 2023-07-26 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240927 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20241217 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250317 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250422 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250526 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250624 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250707 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7718270 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |